362 related articles for article (PubMed ID: 26576093)
21. HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience.
Yuan CH; Xiu DR; Jiang B; Li ZF; Li L; Song SB; Zhang TL
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):149-53. PubMed ID: 23558068
[TBL] [Abstract][Full Text] [Related]
22. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
[TBL] [Abstract][Full Text] [Related]
23. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
24. Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin.
Roche B; Roque-Afonso AM; Nevens F; Samuel D
Transplantation; 2015 Jul; 99(7):1321-34. PubMed ID: 26038873
[TBL] [Abstract][Full Text] [Related]
25. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
26. Management of patients with hepatitis B in special populations.
Cholongitas E; Tziomalos K; Pipili C
World J Gastroenterol; 2015 Feb; 21(6):1738-48. PubMed ID: 25684938
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation for Hepatitis-B-associated liver disease - Three decades of experience.
Teegen EM; Maurer MM; Globke B; Pratschke J; Eurich D
Transpl Infect Dis; 2019 Feb; 21(1):e12997. PubMed ID: 30203903
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin.
Buti M; Tabernero D; Mas A; Homs M; Prieto M; Rodríguez-Frías F; Casafont F; Casillas R; González A; Miras M; Herrero JI; Castells L; Esteban R
Transpl Infect Dis; 2015 Apr; 17(2):208-20. PubMed ID: 25641570
[TBL] [Abstract][Full Text] [Related]
29. Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
Gao YJ; Zhang M; Jin B; Meng FP; Ma XM; Liu ZW; Su HB; Zhao JM; Li HW
J Gastroenterol Hepatol; 2014 Mar; 29(3):554-60. PubMed ID: 24117714
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for viral hepatitis in 2015.
Ferrarese A; Zanetto A; Gambato M; Bortoluzzi I; Nadal E; Germani G; Senzolo M; Burra P; Russo FP
World J Gastroenterol; 2016 Jan; 22(4):1570-81. PubMed ID: 26819523
[TBL] [Abstract][Full Text] [Related]
31. Prevention of recurrent hepatitis B infection after liver transplantation.
Wong TC; Fung JY; Lo CM
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):465-72. PubMed ID: 24103275
[TBL] [Abstract][Full Text] [Related]
32. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation.
Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG
J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257
[TBL] [Abstract][Full Text] [Related]
33. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Wadhawan M; Gupta S; Goyal N; Taneja S; Kumar A
Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
[TBL] [Abstract][Full Text] [Related]
34. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
Yang Y; Zhang Q; Cai CJ; Lu MQ; Li X; Jiang N; Jiang H; Xu C; Li H; Wang GS; Yi SH; Zhang J; Zhang JF; Yi HM; Zhang YC; Chen GH
Chin Med J (Engl); 2007 Aug; 120(16):1400-3. PubMed ID: 17825167
[TBL] [Abstract][Full Text] [Related]
36. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
Lee S; Kwon CH; Moon HH; Kim TS; Roh Y; Song S; Shin M; Kim JM; Park JB; Kim SJ; Joh JW; Lee SK
Clin Transplant; 2013; 27(5):E597-604. PubMed ID: 24093615
[TBL] [Abstract][Full Text] [Related]
37. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease.
Chen FW; Coyle L; Jones BE; Pattullo V
Liver Int; 2013 Sep; 33(8):1203-10. PubMed ID: 23522150
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data.
Öcal S; Korkmaz M; Harmancı Ö; Ensaroğlu F; Akdur A; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():133-8. PubMed ID: 25894142
[TBL] [Abstract][Full Text] [Related]
39. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
Fernández I; Loinaz C; Hernández O; Abradelo M; Manrique A; Calvo J; Manzano M; García A; Cambra F; Castellano G; Jiménez C
Transpl Infect Dis; 2015 Oct; 17(5):695-701. PubMed ID: 26257166
[TBL] [Abstract][Full Text] [Related]
40. Decision analysis model for hepatitis B prophylaxis one year after liver transplantation.
Saab S; Ham MY; Stone MA; Holt C; Tong M
Liver Transpl; 2009 Apr; 15(4):413-20. PubMed ID: 19326401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]